To include your compound in the COVID-19 Resource Center, submit it here.

Medtronic hires Yale to review InFuse following safety questions

Medtronic Inc. (NYSE:MDT) commissioned Yale University to review the safety and efficacy of

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE